The role of interstitial HDR brachytherapy in the treatment of pre-irradiated oral cavity- and oropharyngeal cancers

被引:0
|
作者
Warszawski, A [1 ]
Baumann, R [1 ]
Eckardt, A [1 ]
Stieve, M [1 ]
Karstens, JH [1 ]
机构
[1] Hannover Med Sch, Hannover, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:26 / 26
页数:1
相关论文
共 34 条
  • [21] Interstitial Brachytherapy with Ir-192 Low-Dose-Rate in the Treatment of Primary and Recurrent Cancer the Oral Cavity and Oropharynx
    Gerhard G. Grabenbauer
    Claus Rödel
    Thomas Brunner
    Stefan Schulze-Mosgau
    Vratislav Strnad
    Reinhold G. Müller
    Heiner Iro
    Rolf Sauer
    Strahlentherapie und Onkologie, 2001, 177 : 338 - 344
  • [22] Evaluation of An Automatic Interstitial Catheter Digitization Algorithm That Reduces Treatment Planning Time and Provide Means for Adaptive Re-Planning in HDR Brachytherapy of Gynecologic Cancers
    Dise, J.
    Liang, X.
    Lin, L.
    Teo, B.
    MEDICAL PHYSICS, 2014, 41 (06) : 488 - 488
  • [23] Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay
    Tsujikawa, Tetsuya
    Narita, Norihiko
    Kanno, Masafumi
    Takabayashi, Tetsuji
    Fujieda, Shigeharu
    Okazawa, Hidehiko
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [24] Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay
    Tsujikawa, Tetsuya
    Narita, Norihiko
    Kanno, Masafumi
    Takabayashi, Tetsuji
    Fujieda, Shigeharu
    Okazawa, Hidehiko
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (04) : 239 - 249
  • [25] Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay
    Tetsuya Tsujikawa
    Norihiko Narita
    Masafumi Kanno
    Tetsuji Takabayashi
    Shigeharu Fujieda
    Hidehiko Okazawa
    Annals of Nuclear Medicine, 2018, 32 : 239 - 249
  • [26] Role of Interstitial PDR Brachytherapy in the Treatment of Oral and Oropharyngeal CancerA Single–Institute Experience of 236 PatientsStellenwert der interstitiellen PDR-Brachytherapie in der Behandlung von Mundhöhlen– und Oropharynxkarzinom
    Vratislav Strnad
    Winfried Melzner
    Matthias Geiger
    Johannes Zenk
    Frank Waldfahrer
    Michael Lotter
    Oliver Ott
    Annedore Seeger
    Heinrich Iro
    Rolf Sauer
    Strahlentherapie und Onkologie, 2005, 181 : 762 - 767
  • [27] Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: An institutional experience of 42 cases in India
    Chakrabarti, Bikramjit
    Ghorai, Suman
    Basu, Bishan
    Ghosh, Sajal Kumar
    Gupta, Phalguni
    Ghosh, Kousik
    Ghosh, Pramit
    BRACHYTHERAPY, 2010, 9 (03) : 254 - 259
  • [28] The Role of Hospital Safety-Net Burden in the Treatment of Oral Cavity Cancers: Evaluating its Impact on Survival Outcomes
    Lam, C. M.
    Qureshi, M. M.
    Park, J. J.
    Truong, M. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E404 - E404
  • [29] Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx -: Review of 318 patients treated between 1985 and 1997
    Grabenbauer, GG
    Rödel, C
    Brunner, T
    Schulze-Mosgau, S
    Strnad, V
    Müller, RG
    Iro, H
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (07) : 338 - 344
  • [30] Treatment of Oral Cavity and Oropharyngeal CancerIndications, Technical Aspects, and Results of Interstitial BrachytherapyTherapie von Mundhöhlen- und Oropharynxkarzinomen. Indikationen, technische Aspekte und Ergebnisse der interstitiellen Brachytherapie
    Vratislav Strnad
    Strahlentherapie und Onkologie, 2004, 180 : 710 - 717